Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-26-049698
Filing Date
2026-04-30
Accepted
2026-04-30 07:15:41
Documents
23
Period of Report
2026-06-09

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0287361-03.htm   iXBRL DEF 14A 1802017
2 GRAPHIC toptimizere_logo.jpg GRAPHIC 65307
7 GRAPHIC timage_001.jpg GRAPHIC 209807
8 GRAPHIC timage_002.jpg GRAPHIC 375554
9 GRAPHIC tbarchart_001.jpg GRAPHIC 258924
10 GRAPHIC tbarchart_002.jpg GRAPHIC 256373
11 GRAPHIC tproxy_001.jpg GRAPHIC 1088629
12 GRAPHIC tproxy_002.jpg GRAPHIC 1182917
  Complete submission text file 0001213900-26-049698.txt   10823810

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE oprx-20260430.xsd EX-101.SCH 10575
4 XBRL DEFINITION FILE oprx-20260430_def.xml EX-101.DEF 7862
5 XBRL LABEL FILE oprx-20260430_lab.xml EX-101.LAB 31198
6 XBRL PRESENTATION FILE oprx-20260430_pre.xml EX-101.PRE 10360
26 EXTRACTED XBRL INSTANCE DOCUMENT ea0287361-03_htm.xml XML 346856
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38543 | Film No.: 26920055
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)